SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biohaven Presents Preclinical Data on BHV-1420

Biohaven presented preclinical data on BHV-1420 for membranous nephropathy.

BHVN

Related stories